Are there any outcome measures that suggest a favorable vascular effect with TZDs?

- May 16, 2008

Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.

CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!

Presentation

"Are there any outcome measures that suggest a favorable vascular effect with TZDs?"

Dr. Julio Rosenstock (biography)
English - 2004-06-04 - 15 minutes

(4 slides)

Summary :
Numerous outcome studies are ongoing to test the durability of TZD treatment and their effects on cardiovascular risk and diabetes prevention. Dr. Rosenstock provides a recap of these studies stating their main objectives and the medications being tested.

Copyright © 2004 E-MedHosting.com Inc.

Learning objectives :
After viewing these slides the participant will be able to discuss:

- Outcome studies with TZDs testing their durability, cardiovascular effects and ability to prevent diabetes:
--->ADOPT
--->DREAM
--->RECORD
--->BARI 2D
--->PROactive
--->PERISCOPE
--->CHICAGO

Login

	Username :
	Password :

	Lost your password?

Search our website

Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes.

Social

Let others know about this presentation.

	Del.icio.us
	Digg!

ezCME: HIV - Insulin Resistance - C-Reactive Protein (CRP) - ADHD - Sleep Disorder - Prostate Health - Hemophilia - Transplantation

Copyright © 2002-2008 E-MedHosting.com. All rights reserved. Disclaimer
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.